Inhibitory mechanisms of very low–dose rivaroxaban in non–ST-elevation myocardial infarction
No. | 37 |
---|---|
Citation | Blood Adv 2(6),p715-730(2018) |
Institute | University of Tübingen |
1st Author | O Borst |
AR | ○ |
PL | ○ |
HD | |
Paper types | Clinical investigations |
Main purpose | Drug efficacy evaluation |
Disease | ACS |
Antiplatelet drug | Aspirin, Clopidogrel, Ticagrelor |
Anticoagulant drug | Rivaroxaban |
Other drug | |
Clinical specimens | |
Animal | |
Keyword |